Breast Cancer and Green Tea

matcha green tea powderEpigallocatechin-3-gallate (EGCG), the main constituent of green tea, was found to stabilize p27Kip1 (a gene that regulates cell division, arresting cells in the G1 phase) levels in breast cancer. Thus, it helps to prevent breast cancer cells from dividing and multiplying. In a concentration-dependent manner, EGCG decreases the migratory and invasive potential of breast cancer cells. Green tea and EGCG inhibits the enzyme fatty acid synthase, causing cell death in breast cancer cells. It also inhibits the formation of a blood supply to a growing tumor, stalling tumor growth. Green tea and its components decrease cellular damage caused by oxidative stress (free radicals). EGCG induces apoptosis (cell death) in breast cancer cells and promotes cell growth arrest, by altering the expression of cell cycle regulatory proteins, activating killer caspases, and suppressing nuclear factor kappa-B activation. Besides, it regulates and promotes IL-23 dependent DNA repair and stimulates cytotoxic T cells activities in a tumor microenvironment. It also blocks carcinogenesis by modulating the signal transduction pathways involved in cell proliferation, transformation, inflammation and metastasis. Consumption of more than 3 cups a day of green tea decreases recurrence of breast cancer and decreases breast density. Studies show that water-soluble oligomeric epicatechins surpass EGCG in stability, selectivity and efficacy at lower doses.

Share this postShare on FacebookTweet about this on TwitterShare on Google+Email this to someone